These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 10976920)

  • 1. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
    Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
    Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
    Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W
    Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo.
    Cesario RM; Klausing K; Razzaghi H; Crombie D; Rungta D; Heyman RA; Lala DS
    Mol Endocrinol; 2001 Aug; 15(8):1360-9. PubMed ID: 11463859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes.
    Camp HS; Chaudhry A; Leff T
    Endocrinology; 2001 Jul; 142(7):3207-13. PubMed ID: 11416043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
    Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB
    Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes.
    Shimaya A; Kurosaki E; Shioduka K; Nakano R; Shibasaki M; Shikama H
    Horm Metab Res; 1998 Sep; 30(9):543-8. PubMed ID: 9808320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
    Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S
    Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
    Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
    Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation.
    Wright HM; Clish CB; Mikami T; Hauser S; Yanagi K; Hiramatsu R; Serhan CN; Spiegelman BM
    J Biol Chem; 2000 Jan; 275(3):1873-7. PubMed ID: 10636887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes.
    Tamori Y; Masugi J; Nishino N; Kasuga M
    Diabetes; 2002 Jul; 51(7):2045-55. PubMed ID: 12086932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of adipogenesis by a COOH-terminally truncated mutant of PPARgamma2 in 3T3-L1 cells.
    Masugi J; Tamori Y; Kasuga M
    Biochem Biophys Res Commun; 1999 Oct; 264(1):93-9. PubMed ID: 10527847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.
    Rizzo G; Disante M; Mencarelli A; Renga B; Gioiello A; Pellicciari R; Fiorucci S
    Mol Pharmacol; 2006 Oct; 70(4):1164-73. PubMed ID: 16778009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2.
    Li Y; Lazar MA
    Mol Endocrinol; 2002 May; 16(5):1040-8. PubMed ID: 11981038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608.
    Wiesenberg I; Chiesi M; Missbach M; Spanka C; Pignat W; Carlberg C
    Mol Pharmacol; 1998 Jun; 53(6):1131-8. PubMed ID: 9614218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.
    Berger J; Tanen M; Elbrecht A; Hermanowski-Vosatka A; Moller DE; Wright SD; Thieringer R
    J Biol Chem; 2001 Apr; 276(16):12629-35. PubMed ID: 11278270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artepillin C, as a PPARĪ³ ligand, enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS; Cha BY; Iida K; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
    Biochem Pharmacol; 2011 Apr; 81(7):925-33. PubMed ID: 21219874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
    Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3.
    Chan SS; Schedlich LJ; Twigg SM; Baxter RC
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E654-63. PubMed ID: 19141684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
    Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
    Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes.
    Takamura T; Nohara E; Nagai Y; Kobayashi K
    Eur J Pharmacol; 2001 Jun; 422(1-3):23-9. PubMed ID: 11430909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.